Skander Essafi
Skander Essafi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Amel Letaief
Univ Hosp Farhat Hached Sousse, Infect Dis Dept, Ibn Jazzar St, Sousse 4000, Tunisia
1 shared publication- Amel Letaief
Infectious Diseases Department, Farhat Hached University Hospital, Ibn El Jazzar Medical School, University of Sousse, Sousse, Tunisia
1 shared publication E van Eck
Innovation Lab, GGD West-Brabant , Breda
1 shared publicationEmma Phillips
Costello Med, Cambridge, England
1 shared publicationK Tabeau
Erasmus School Health Policy Management, Erasmus University Rotterdam , Rotterdam
1 shared publication- Maha Abid
Farhat Hached Univ Hosp, Dept Infect Dis, Sousse 4000, Tunisia
1 shared publication
Latest Publications
- Open Access
- 28 October 2024
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 34 (Supplement)
Public health innovation labs framework development: a design study of GGD West-Brabant Netherlands
Introduction: Innovation Labs are spaces that encourage the creation, development and testing of novel ideas within organizations.While there are known frameworks for the organization of such labs in the private sector, current literature does not reflect a framework for developing a public health Innovation Lab (PHI-Lab) specifically.The aim of this study was to develop an evidence-based framework for a PHI-Lab together with the Dutch Municipal Health Service(GGD). Methods: Our design thinking study consisted of 4 phases: Discovering, Defining, Creating and Evaluating.An initial framework was developed based on the public and public health sectors in the literature.To create and evaluate the framework,a document analysis of the GGD was performed,and co-creation and testing sessions were organized with 11 internal and 11 external stakeholders of the GGD. Results: The final PHI-Lab framework is composed of: rationale, enablers and barriers, environment, approach, outcomes and values. Findings emphasized practical reasons for investing in a PHI-Lab, such as the shortage of health professionals.Stakeholders highlighted that proactive leadership and innovation culture are crucial enablers for the setup of the PHI-Lab.The right space and human resources (environment) and methods including design thinking and cross-collaboration (approach) were highlighted as important strategies for overcoming innovation challenges.Despite barriers such as bureaucracy and resource limitations, tailoring solutions to organizational objectives is key to the PHI-Lab’s success and sustainability, with added values of inclusiveness, adaptability and fun. Conclusions: This study highlighted some practical additions to the initial framework that are specific to the public health setting, although mostly an adaptation from the public sector.Findings emphasize that there isn’t a one-size-fits-all solution to develop a PHI-Lab.This framework has the intention of benefiting other public health organizations. Key messages: • The framework has the intention of benefiting other public health organizations within established networks and partnerships. • Proactive leadership and innovation culture are crucial enablers for the organizational setup of the innovation lab.
- 28 October 2024
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 34 (Supplement)
Open AccessPublic health innovation labs framework development: a design study of GGD West-Brabant Netherlands
Introduction: Innovation Labs are spaces that encourage the creation, development and testing of novel ideas within organizations.While there are known frameworks for the organization of such labs in the private sector, current literature does not reflect a framework for developing a public health Innovation Lab (PHI-Lab) specifically.The aim of this study was to develop an evidence-based framework for a PHI-Lab together with the Dutch Municipal Health Service(GGD). Methods: Our design thinking study consisted of 4 phases: Discovering, Defining, Creating and Evaluating.An initial framework was developed based on the public and public health sectors in the literature.To create and evaluate the framework,a document analysis of the GGD was performed,and co-creation and testing sessions were organized with 11 internal and 11 external stakeholders of the GGD. Results: The final PHI-Lab framework is composed of: rationale, enablers and barriers, environment, approach, outcomes and values. Findings emphasized practical reasons for investing in a PHI-Lab, such as the shortage of health professionals.Stakeholders highlighted that proactive leadership and innovation culture are crucial enablers for the setup of the PHI-Lab.The right space and human resources (environment) and methods including design thinking and cross-collaboration (approach) were highlighted as important strategies for overcoming innovation challenges.Despite barriers such as bureaucracy and resource limitations, tailoring solutions to organizational objectives is key to the PHI-Lab’s success and sustainability, with added values of inclusiveness, adaptability and fun. Conclusions: This study highlighted some practical additions to the initial framework that are specific to the public health setting, although mostly an adaptation from the public sector.Findings emphasize that there isn’t a one-size-fits-all solution to develop a PHI-Lab.This framework has the intention of benefiting other public health organizations. Key messages: • The framework has the intention of benefiting other public health organizations within established networks and partnerships. • Proactive leadership and innovation culture are crucial enablers for the organizational setup of the innovation lab.
- Open Access
- 11 October 2023
- Published by IntechOpen
Recurrent Cystitis in Women: Optimal Recommended Diagnostic Evaluation, Management and Prevention Options
Cystitis is a very common infection of the lower urinary tract. Women are typically affected, and more than 30 percent will experience at least one episode of cystitis in their lifetime. The diagnosis of this condition and its management are widely known and applied in the outpatient healthcare setting. However, recurrent cystitis, associated with a significant morbidity, is more challenging since their diagnostic evaluation, management and prevention differ significantly between disciplines. Several treatment and prevention options are offered to women with recurrent cystitis. Antibiotic prevention and treatment options should not be first-line, given the importance to limit resistance development and efficacy of alternatives in most situations. The proposed chapter is a narrative review on the current state-of-the-art for the diagnostic evaluation, management and prevention of recurrent cystitis, and aims to discuss other issues and aspects that could be addressed for an optimal management of this condition.
- 11 October 2023
- Published by IntechOpen
Open AccessRecurrent Cystitis in Women: Optimal Recommended Diagnostic Evaluation, Management and Prevention Options
Cystitis is a very common infection of the lower urinary tract. Women are typically affected, and more than 30 percent will experience at least one episode of cystitis in their lifetime. The diagnosis of this condition and its management are widely known and applied in the outpatient healthcare setting. However, recurrent cystitis, associated with a significant morbidity, is more challenging since their diagnostic evaluation, management and prevention differ significantly between disciplines. Several treatment and prevention options are offered to women with recurrent cystitis. Antibiotic prevention and treatment options should not be first-line, given the importance to limit resistance development and efficacy of alternatives in most situations. The proposed chapter is a narrative review on the current state-of-the-art for the diagnostic evaluation, management and prevention of recurrent cystitis, and aims to discuss other issues and aspects that could be addressed for an optimal management of this condition.
- 1 January 2021
- Published by Termedia Sp. z.o.o. in Family Medicine & Primary Care Review
- Vol. 23 (3) , 295-300
Antimicrobial stewardship and economic evaluation of urinary tract infection management in primary health care in Tunisia
Background Inappropriate antibiotic prescriptions significantly contribute to antimicrobial resistance and are common in urinary tract infections (UTI) in primary health care. Tunisian guidelines were developed to improve UTI management for General Practitioners (GPs). Objectives This study...
- 1 January 2021
- Published by Termedia Sp. z.o.o. in Family Medicine & Primary Care Review
- Vol. 23 (3) , 295-300
Antimicrobial stewardship and economic evaluation of urinary tract infection management in primary health care in Tunisia
Background Inappropriate antibiotic prescriptions significantly contribute to antimicrobial resistance and are common in urinary tract infections (UTI) in primary health care. Tunisian guidelines were developed to improve UTI management for General Practitioners (GPs). Objectives This study...